ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.22
0.03%
US Tech 100
19,287.60
-0.24%
S&P 500
5,702.55
-0.19%
US Dollar vs CAD
1.35775
0.00%
Bitcoin
62,951.05
-0.67%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. CytomX Therapeutics Inc (CTMX)

  7. CytomX Therapeutics Inc (CTMX) News

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CTMX
DateTimeSourceHeadlineSymbolCompany
09/09/20247:00AMGlobeNewswire Inc.CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid TumorsNASDAQ:CTMXCytomX Therapeutics Inc
09/04/20247:00AMGlobeNewswire Inc.CytomX Therapeutics to Present at Upcoming September Investor ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
08/22/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
08/22/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
08/22/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
08/22/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
08/19/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CTMXCytomX Therapeutics Inc
08/09/20243:06PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CTMXCytomX Therapeutics Inc
08/08/20243:10PMGlobeNewswire Inc.CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
08/08/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTMXCytomX Therapeutics Inc
08/08/20243:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTMXCytomX Therapeutics Inc
08/01/20247:00AMGlobeNewswire Inc.CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:CTMXCytomX Therapeutics Inc
06/18/20247:00AMGlobeNewswire Inc.CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
06/17/20243:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTMXCytomX Therapeutics Inc
06/17/20243:15PMGlobeNewswire Inc.CytomX Therapeutics Promotes Chris Ogden to Chief Financial OfficerNASDAQ:CTMXCytomX Therapeutics Inc
06/14/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
05/22/20243:05PMGlobeNewswire Inc.CytomX Therapeutics to Present at the Jefferies Global Healthcare ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
05/17/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
05/17/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
05/17/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
05/17/20244:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
05/17/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTMXCytomX Therapeutics Inc
05/17/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTMXCytomX Therapeutics Inc
05/16/20243:15PMGlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantsNASDAQ:CTMXCytomX Therapeutics Inc
05/13/20243:00PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CTMXCytomX Therapeutics Inc
05/08/20243:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTMXCytomX Therapeutics Inc
05/08/20243:10PMGlobeNewswire Inc.CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)NASDAQ:CTMXCytomX Therapeutics Inc
05/08/20243:10PMGlobeNewswire Inc.CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
05/08/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTMXCytomX Therapeutics Inc
05/08/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

Your Recent History

NASDAQ
AMRN
Amarin
USOTC
MONI
Moon Equity (PK)
NASDAQ
AVXL
Anavex Life Sciences
NYSE
GME
GameStop
USOTC
AABB
Asia Broadband (PK)
NASDAQ
NB
NioCorp Developments
NASDAQ
COOP
Mr Cooper
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RNVA
Rennova Health (CE)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved